{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:52:26Z","timestamp":1794358346432,"version":"4.9.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Tuberculosis caused by <jats:italic>Mycobacterium tuberculosis<\/jats:italic> complex is a significant global health burden, with drug-resistant TB, especially multidrug-resistant TB, causing severe challenges to treatment. In Ethiopia, a high TB-burden country, drug resistance has continued spreading. However, some studies indicate genetic diversity, transmission dynamics, and resistance-conferring mutations by using targeted amplification, there are limited reports of whole genome sequencing analysis to uncover the antimicrobial resistance and virulent genes. Based on that, the objective of this project was to identify antimicrobial resistance regions and characterize virulence factors in <jats:italic>M. tuberculosis<\/jats:italic> isolates through in silico whole-genome sequence analysis. A FASTQ file of 45 <jats:italic>M. tuberculosis<\/jats:italic> isolates whole genome sequence was downloaded from the SAR database. Following quality control using FASTQC coupled with MultiQC and trimming with Trimmomatic, de novo assembly was conducted using SPAdes. The Burrows-Wheeler Aligner was used for mapping against the <jats:italic>M. tuberculosis<\/jats:italic> H37Rv reference genome, followed by variant calling with FreeBayes. In silico spoligotyping was performed using SpoTyping, and drug resistance mutations were identified with TB-Profiler and validated using Mykrobe. Virulence factors were detected through ABRicate and the Virulence Factor Database. STRING was used to network the virulent genes. All statistical analyses were performed using R software. This study revealed the most prevalent TB-lineage in the Amhara region was L4 (58.53%), followed by L3 (34.15%), and L1 (4.88%), and in silico spoligotyping classified 90.24% of the isolates into 12 shared types, with SIT 149 (41.46%) and SIT 21 (14.63%) as the most frequent spoligotypes. Seven major genotypic families were identified, with T3-ETH being the dominant family (48.78%). Drug resistance analysis revealed that 38 isolates (92.7%) were multidrug-resistant, and 1 (2.4%) was pre-extensively drug-resistant. Lineage 4 (59%) and its sub-lineage 4.2.2 (51.3%) show the highest resistance. The most frequent mutations to rifampicin, isoniazid, pyrazinamide, ethambutol, streptomycin, ethionamide, fluoroquinolone, and 2nd-line injectable drugs occurred at <jats:italic>rpoB<\/jats:italic> Ser450Leu, <jats:italic>katG<\/jats:italic> Ser315Thr, <jats:italic>pncA<\/jats:italic> c.-11A\u2009&gt;\u2009G, <jats:italic>embB<\/jats:italic> Gly406Ala, <jats:italic>rpsL<\/jats:italic> Lys43Arg, Lys88Thr, <jats:italic>ethA<\/jats:italic> Met1, <jats:italic>gyrA<\/jats:italic> Ala90Val, Asp94Asn, and <jats:italic>rrs<\/jats:italic> 1401A\u2009&gt;\u2009G, respectively. Additionally, a mutation at the <jats:italic>mmpR5<\/jats:italic> gene for bedaquiline and clofazimine resistance occurred in one isolate. A total of 67 virulence genes were identified and 63 of them occurred in all isolates. The high prevalence of MDR-TB and the detection of resistance to both first- and second-line drugs in this study underscore the urgent need for enhanced TB control measures in the Amhara region.<\/jats:p>","DOI":"10.1038\/s41598-025-01241-6","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:06:47Z","timestamp":1746706007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Whole-genome sequencing analysis to identify antimicrobial resistance regions and virulence factors in Mycobacterium tuberculosis isolates from the Amhara Region, Ethiopia"],"prefix":"10.1038","volume":"15","author":[{"given":"Abebe Tesfaye","family":"Gessese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mebrie Zemene","family":"Kinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tegegne","family":"Eshetu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bizuayehu","family":"Kerisew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"2","key":"1241_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cll.2014.02.005","volume":"34","author":"SYG Lin","year":"2014","unstructured":"Lin, S. Y. G. & Desmond, E. P. Molecular diagnosis of tuberculosis and drug resistance. Clin. Lab. Med. 34(2), 297\u2013314 (2014).","journal-title":"Clin. Lab. Med."},{"issue":"6","key":"1241_CR2","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.3390\/ijms24065202","volume":"24","author":"SSR Alsayed","year":"2023","unstructured":"Alsayed, S. S. R. & Gunosewoyo, H. Tuberculosis: pathogenesis, current treatment regimens and new drug targets. Int. J. Mol. Sci. 24(6), 5202 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1241_CR3","unstructured":"WHO. Global tuberculosis report 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO [Internet]. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024 (2024)."},{"key":"1241_CR4","unstructured":"WHO Africa. Country Disease Outlook Ethiopia, 55\u201358. https:\/\/www.afro.who.int\/sites\/default\/files\/2023-08\/Ethiopia.pdf (2023)."},{"key":"1241_CR5","unstructured":"US Agency for International Development. Ethiopia tuberculosis roadmap overview, Fiscal Year 2023. https:\/\/www.usaid.gov\/sites\/default\/files\/2024-02\/Ethiopia_TB_roadmap_narrative_22_508.pdf (2023)."},{"issue":"7","key":"1241_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180996","volume":"12","author":"CC Onyedum","year":"2017","unstructured":"Onyedum, C. C., Alobu, I. & Ukwaja, K. N. Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and meta-analysis. PLoS ONE 12(7), e0180996 (2017).","journal-title":"PLoS ONE"},{"key":"1241_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.micpath.2018.02.047","volume":"117","author":"M Saravanan","year":"2018","unstructured":"Saravanan, M. et al. Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia. Microb. Pathog. 117, 237\u2013242 (2018).","journal-title":"Microb. Pathog."},{"issue":"1","key":"1241_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12879-019-3978-3","volume":"19","author":"A Alelign","year":"2019","unstructured":"Alelign, A. et al. Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia. BMC Infect. Dis. 19(1), 343 (2019).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"1241_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-2334-13-131","volume":"13","author":"B Tessema","year":"2013","unstructured":"Tessema, B. et al. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in Northwest Ethiopia: new phylogenetic lineages found in Northwest Ethiopia. BMC Infect. Dis. 13(1), 131 (2013).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"1241_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082235","volume":"9","author":"YM Mesfin","year":"2014","unstructured":"Mesfin, Y. M., Hailemariam, D., Biadglign, S. & Kibret, K. T. Association between HIV\/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS ONE 9(1), e82235 (2014).","journal-title":"PLoS ONE"},{"key":"1241_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nmni.2017.02.003","volume":"17","author":"Z Bedewi","year":"2017","unstructured":"Bedewi, Z. et al. Mycobacterium tuberculosis in central Ethiopia: drug sensitivity patterns and association with genotype. New Microbes New Infect. 17, 69\u201374 (2017).","journal-title":"New Microbes New Infect."},{"issue":"5","key":"1241_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.34297\/AJBSR.2020.07.001181","volume":"7","author":"AO Abraham","year":"2020","unstructured":"Abraham, A. O. Mechanism of drug resistance in Mycobacterium Tuberculosis. Am. J. Biomed. Sci. Res. 7(5), 378\u2013383 (2020).","journal-title":"Am. J. Biomed. Sci. Res."},{"key":"1241_CR13","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000477","author":"M Coscolla","year":"2021","unstructured":"Coscolla, M. et al. Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history. Microb. Genom. https:\/\/doi.org\/10.1099\/mgen.0.000477 (2021).","journal-title":"Microb. Genom."},{"key":"1241_CR14","doi-asserted-by":"publisher","first-page":"baaa108","DOI":"10.1093\/database\/baaa108","volume":"2020","author":"D Couvin","year":"2020","unstructured":"Couvin, D., Segretier, W., Stattner, E. & Rastogi, N. Novel methods included in SpolLineages tool for fast and precise prediction of Mycobacterium tuberculosis complex spoligotype families. Database 2020, baaa108 (2020).","journal-title":"Database"},{"issue":"1","key":"1241_CR15","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1038\/s41467-020-16626-6","volume":"11","author":"JCS Ngabonziza","year":"2020","unstructured":"Ngabonziza, J. C. S. et al. A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region. Nat. Commun. 11(1), 2917 (2020).","journal-title":"Nat. Commun."},{"issue":"12","key":"1241_CR16","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/ng.3704","volume":"48","author":"D Stucki","year":"2016","unstructured":"Stucki, D. et al. Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages. Nat. Genet. 48(12), 1535\u20131543 (2016).","journal-title":"Nat. Genet."},{"issue":"1","key":"1241_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4046\/trd.2019.0065","volume":"83","author":"BW Jhun","year":"2020","unstructured":"Jhun, B. W. & Koh, W. J. Treatment of isoniazid-resistant pulmonary tuberculosis. Tuberc. Respir. Dis. 83(1), 20 (2020).","journal-title":"Tuberc. Respir. Dis."},{"key":"1241_CR18","unstructured":"Centers for Disease Control and Prevention. Clinical overview of drug-resistant tuberculosis disease. https:\/\/www.cdc.gov\/tb\/hcp\/clinical-overview\/drug-resistant-tuberculosis-disease.html (2024)."},{"key":"1241_CR19","unstructured":"WHO. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis. [cited 2025 Mar 3]. https:\/\/www.who.int\/publications\/i\/item\/9789240018662."},{"key":"1241_CR20","unstructured":"Catalogue of Mutations in Mycobacterium Tuberculosis Complex and Their Association with Drug Resistance, 2nd ed. (World Health Organization, 2023)."},{"key":"1241_CR21","first-page":"19","volume":"8","author":"M Muthaiah","year":"2017","unstructured":"Muthaiah, M. et al. Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates. J. Clin. Tuberc. Mycobact. Dis. 8, 19\u201325 (2017).","journal-title":"J. Clin. Tuberc. Mycobact. Dis."},{"key":"1241_CR22","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.2147\/IDR.S407525","volume":"16","author":"B Cao","year":"2023","unstructured":"Cao, B. et al. Genetic characterization conferred co-resistance to isoniazid and ethionamide in Mycobacterium tuberculosis isolates from Southern Xinjiang, China. Infect. Drug Resist. 16, 3117\u20133135 (2023).","journal-title":"Infect. Drug Resist."},{"key":"1241_CR23","first-page":"1","volume":"2013","author":"Z Baku\u0142a","year":"2013","unstructured":"Baku\u0142a, Z. et al. Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland. BioMed. Res. Int. 2013, 1\u20135 (2013).","journal-title":"BioMed. Res. Int."},{"issue":"12","key":"1241_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.743198","volume":"6","author":"LN Welekidan","year":"2021","unstructured":"Welekidan, L. N. et al. Whole genome sequencing of drug resistant and drug susceptible Mycobacterium tuberculosis isolates from Tigray Region, Ethiopia. Front. Microbiol. 6(12), 743198 (2021).","journal-title":"Front. Microbiol."},{"key":"1241_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2022.102184","volume":"133","author":"P Bwalya","year":"2022","unstructured":"Bwalya, P. et al. Characterization of embB mutations involved in ethambutol resistance in multi-drug resistant Mycobacterium tuberculosis isolates in Zambia. Tuberculosis 133, 102184 (2022).","journal-title":"Tuberculosis"},{"issue":"2","key":"1241_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3947\/ic.2023.0037","volume":"55","author":"NY Kim","year":"2023","unstructured":"Kim, N. Y., Kim, D. Y., Chu, J. & Jung, S. H. pncA large deletion is the characteristic of pyrazinamide-resistant Mycobacterium tuberculosis belonging to the East Asian Lineage. Infect. Chemother. 55(2), 247 (2023).","journal-title":"Infect. Chemother."},{"issue":"7","key":"1241_CR27","first-page":"2713","volume":"12","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. The roles of rpsL, rrs, and gidB mutations in predicting streptomycin-resistant drugs used on clinical Mycobacterium tuberculosis isolates from Hebei Province, China. Int. J. Clin. Exp. Pathol. 12(7), 2713\u20132721 (2019).","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"1241_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1128\/JCM.02775-15","volume":"54","author":"MR Farhat","year":"2016","unstructured":"Farhat, M. R. et al. Gyrase mutations are associated with variable levels of fluoroquinolone resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 54(3), 727\u2013733 (2016).","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"1241_CR29","doi-asserted-by":"publisher","first-page":"2150449","DOI":"10.1080\/21505594.2022.2150449","volume":"14","author":"KC Rahlwes","year":"2023","unstructured":"Rahlwes, K. C., Dias, B. R. S., Campos, P. C., Alvarez-Arguedas, S. & Shiloh, M. U. Pathogenicity and virulence of Mycobacterium tuberculosis. Virulence. 14(1), 2150449 (2023).","journal-title":"Virulence."},{"issue":"6","key":"1241_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/pathogens12060839","volume":"12","author":"L Ramon-Luing","year":"2023","unstructured":"Ramon-Luing, L., Palacios, Y., Ruiz, A., T\u00e9llez-Navarrete, N. & Chavez-Galan, L. Virulence factors of Mycobacterium tuberculosis as modulators of cell death mechanisms. Pathogens. 12(6), 839 (2023).","journal-title":"Pathogens."},{"issue":"14","key":"1241_CR31","doi-asserted-by":"publisher","first-page":"1211267","DOI":"10.3389\/fmicb.2023.1211267","volume":"30","author":"D Mekonnen","year":"2023","unstructured":"Mekonnen, D. et al. Comparative whole-genome sequence analysis of Mycobacterium tuberculosis isolated from pulmonary tuberculosis and tuberculous lymphadenitis patients in Northwest Ethiopia. Front. Microbiol. 30(14), 1211267 (2023).","journal-title":"Front. Microbiol."},{"issue":"12","key":"1241_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22898","volume":"9","author":"M Agonafir","year":"2023","unstructured":"Agonafir, M. et al. Genetic diversity of Mycobacterium tuberculosis isolates from the central, eastern and southeastern Ethiopia. Heliyon. 9(12), e22898 (2023).","journal-title":"Heliyon."},{"key":"1241_CR33","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.2147\/IDR.S429001","volume":"16","author":"D Mekonnen","year":"2023","unstructured":"Mekonnen, D. et al. Mycobacterium tuberculosis sub-lineage 4.2.2\/SIT149 as dominant drug-resistant clade in Northwest Ethiopia 2020\u20132022: In-silico whole-genome sequence analysis. Infect. Drug Resist. 16, 6859\u20136870 (2023).","journal-title":"Infect. Drug Resist."},{"issue":"12","key":"1241_CR34","doi-asserted-by":"publisher","first-page":"1399731","DOI":"10.3389\/fpubh.2024.1399731","volume":"9","author":"B Chekesa","year":"2024","unstructured":"Chekesa, B. et al. Whole-genome sequencing-based genetic diversity, transmission dynamics, and drug-resistant mutations in Mycobacterium tuberculosis isolated from extrapulmonary tuberculosis patients in western Ethiopia. Front. Public Health. 9(12), 1399731 (2024).","journal-title":"Front. Public Health."},{"issue":"6","key":"1241_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3724\/zdxbyxb-2022-0454","volume":"51","author":"K Bi","year":"2022","unstructured":"Bi, K. et al. The past, present and future of tuberculosis treatment. J. Zhejiang Univ. Med. Sci. 51(6), 657\u2013668 (2022).","journal-title":"J. Zhejiang Univ. Med. Sci."},{"issue":"1","key":"1241_CR36","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12864-023-09502-2","volume":"24","author":"A Shibabaw","year":"2023","unstructured":"Shibabaw, A. et al. Molecular epidemiology and transmission dynamics of multi-drug resistant tuberculosis strains using whole genome sequencing in the Amhara region, Ethiopia. BMC Genom. 24(1), 400 (2023).","journal-title":"BMC Genom."},{"key":"1241_CR37","unstructured":"Babraham Bioinformatics. FastQC: A quality control tool for high throughput sequence data (Version 0.12.0). https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/. 2023. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/"},{"issue":"19","key":"1241_CR38","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & K\u00e4ller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32(19), 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"issue":"15","key":"1241_CR39","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30(15), 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"issue":"1","key":"1241_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.102","volume":"70","author":"A Prjibelski","year":"2020","unstructured":"Prjibelski, A., Antipov, D., Meleshko, D., Lapidus, A. & Korobeynikov, A. Using SPAdes De Novo Assembler. Curr. Protoc. Bioinform. 70(1), e102 (2020).","journal-title":"Curr. Protoc. Bioinform."},{"issue":"13","key":"1241_CR41","doi-asserted-by":"publisher","first-page":"i142","DOI":"10.1093\/bioinformatics\/bty266","volume":"34","author":"A Mikheenko","year":"2018","unstructured":"Mikheenko, A., Prjibelski, A., Saveliev, V., Antipov, D. & Gurevich, A. Versatile genome assembly evaluation with QUAST-LG. Bioinformatics 34(13), i142\u2013i150 (2018).","journal-title":"Bioinformatics"},{"key":"1241_CR42","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000699","author":"B Bogaerts","year":"2021","unstructured":"Bogaerts, B. et al. Evaluation of WGS performance for bacterial pathogen characterization with the Illumina technology optimized for time-critical situations. Microb. Genom. https:\/\/doi.org\/10.1099\/mgen.0.000699 (2021).","journal-title":"Microb. Genom."},{"issue":"16","key":"1241_CR43","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinform. Oxf. Engl. 25(16), 2078\u20132079 (2009).","journal-title":"Bioinform. Oxf. Engl."},{"key":"1241_CR44","unstructured":"Garrison, E., Marth, G. Haplotype-based variant detection from short-read sequencing. arXiv; 2012 [cited 2024 Sep 25]. http:\/\/arxiv.org\/abs\/1207.3907."},{"issue":"15","key":"1241_CR45","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","volume":"27","author":"P Danecek","year":"2011","unstructured":"Danecek, P. et al. The variant call format and VCFtools. Bioinformatics 27(15), 2156\u20132158 (2011).","journal-title":"Bioinformatics"},{"issue":"1","key":"1241_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13073-016-0270-7","volume":"8","author":"E Xia","year":"2016","unstructured":"Xia, E., Teo, Y. Y. & Ong, R. T. H. SpoTyping: fast and accurate in silico Mycobacterium spoligotyping from sequence reads. Genome Med. 8(1), 19 (2016).","journal-title":"Genome Med."},{"key":"1241_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13073-019-0650-x","volume":"11","author":"JE Phelan","year":"2019","unstructured":"Phelan, J. E. et al. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs. Genome Med. 11, 41 (2019).","journal-title":"Genome Med."},{"issue":"4","key":"1241_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.12688\/wellcomeopenres.15603.1","volume":"2","author":"M Hunt","year":"2019","unstructured":"Hunt, M. et al. Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe. Wellcome Open Res. 2(4), 191 (2019).","journal-title":"Wellcome Open Res."},{"issue":"D1","key":"1241_CR49","doi-asserted-by":"publisher","first-page":"D694","DOI":"10.1093\/nar\/gkv1239","volume":"44","author":"L Chen","year":"2016","unstructured":"Chen, L., Zheng, D., Liu, B., Yang, J. & Jin, Q. VFDB 2016: hierarchical and refined dataset for big data analysis\u201410 years on. Nucleic Acids Res. 44(D1), D694\u2013D697 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1241_CR50","unstructured":"Seemann, T. ABRicate: mass screening of contigs for antiobiotic resistance genes. (2020). https:\/\/github.com\/tseemann\/abricate."},{"key":"1241_CR51","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.2147\/IDR.S468997","volume":"17","author":"D Sadovska","year":"2024","unstructured":"Sadovska, D. et al. Discordance between phenotypic and WGS-based drug susceptibility testing results for some anti-tuberculosis drugs: A snapshot study of paired Mycobacterium tuberculosis isolates with small genetic distance. Infect. Drug Resist. 17, 3289\u20133307 (2024).","journal-title":"Infect. Drug Resist."},{"issue":"1","key":"1241_CR52","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/S2666-5247(23)00252-5","volume":"5","author":"AM Garc\u00eda-Mar\u00edn","year":"2024","unstructured":"Garc\u00eda-Mar\u00edn, A. M. et al. Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis. Lancet Microbe. 5(1), e43-51 (2024).","journal-title":"Lancet Microbe."},{"issue":"6","key":"1241_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218545","volume":"14","author":"D Damena","year":"2019","unstructured":"Damena, D. et al. Genetic diversity and drug susceptibility profiles of Mycobacterium tuberculosis obtained from Saint Peter\u2019s TB specialized Hospital, Ethiopia. PLoS ONE 14(6), e0218545 (2019).","journal-title":"PLoS ONE"},{"key":"1241_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2019.101858","volume":"118","author":"D Mekonnen","year":"2019","unstructured":"Mekonnen, D. et al. Molecular epidemiology of M. tuberculosis in Ethiopia: A systematic review and meta-analysis. Tuberculosis 118, 101858 (2019).","journal-title":"Tuberculosis"},{"issue":"1","key":"1241_CR55","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41597-023-02112-3","volume":"10","author":"M Laamarti","year":"2023","unstructured":"Laamarti, M., El Fathi, L. Y., Elfermi, R., Daoud, R. & El Allali, A. Afro-TB dataset as a large scale genomic data of Mycobacterium tuberuclosis in Africa. Sci. Data. 10(1), 212 (2023).","journal-title":"Sci. Data."},{"key":"1241_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2024.101235","volume":"59","author":"MA Reta","year":"2024","unstructured":"Reta, M. A. et al. Genetic diversity of Mycobacterium tuberculosis strains isolated from spiritual holy water site attendees in Northwest Ethiopia. A cross-sectional study. New Microbes New Infect. 59, 101235 (2024).","journal-title":"New Microbes New Infect."},{"key":"1241_CR57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijid.2020.11.129","volume":"103","author":"M Ejo","year":"2021","unstructured":"Ejo, M. et al. Genetic diversity of the Mycobacterium tuberculosis complex strains from newly diagnosed tuberculosis patients in Northwest Ethiopia reveals a predominance of East-African-Indian and Euro-American lineages. Int. J. Infect. Dis. 103, 72\u201380 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"1241_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2023.105530","volume":"116","author":"A Meaza","year":"2023","unstructured":"Meaza, A. et al. Genomic transmission clusters and circulating lineages of Mycobacterium tuberculosis among refugees residing in refugee camps in Ethiopia. Infect. Genet. Evol. 116, 105530 (2023).","journal-title":"Infect. Genet. Evol."},{"issue":"9","key":"1241_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.960590","volume":"14","author":"G Worku","year":"2022","unstructured":"Worku, G. et al. Molecular epidemiology of tuberculosis in the Somali region, eastern Ethiopia. Front. Med. 14(9), 960590 (2022).","journal-title":"Front. Med."},{"issue":"1","key":"1241_CR60","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1186\/s12879-020-05394-9","volume":"20","author":"B Wondale","year":"2020","unstructured":"Wondale, B. et al. Molecular epidemiology of clinical Mycobacterium tuberculosis complex isolates in South Omo, Southern Ethiopia. BMC Infect. Dis. 20(1), 750 (2020).","journal-title":"BMC Infect. Dis."},{"issue":"12","key":"1241_CR61","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1128\/JCM.01467-14","volume":"52","author":"P Srilohasin","year":"2014","unstructured":"Srilohasin, P. et al. Genetic diversity and dynamic distribution of Mycobacterium tuberculosis isolates causing pulmonary and extrapulmonary tuberculosis in Thailand. J. Clin. Microbiol. 52(12), 4267\u20134274 (2014).","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"1241_CR62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12879-020-05639-7","volume":"21","author":"S Hadifar","year":"2021","unstructured":"Hadifar, S. et al. Variation in Mycobacterium tuberculosis population structure in Iran: a systemic review and meta-analysis. BMC Infect. Dis. 21(1), 2 (2021).","journal-title":"BMC Infect. Dis."},{"key":"1241_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jgar.2022.11.012","volume":"32","author":"M Ejo","year":"2023","unstructured":"Ejo, M. et al. Strain diversity and gene mutations associated with presumptive multidrug-resistant Mycobacterium tuberculosis complex isolates in Northwest Ethiopia. J. Glob. Antimicrob. Resist. 32, 167\u2013175 (2023).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"1241_CR64","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2147\/IDR.S298683","volume":"14","author":"S Ayalew","year":"2021","unstructured":"Ayalew, S. et al. Drug resistance conferring mutation and genetic diversity of Mycobacterium tuberculosis isolates in tuberculosis lymphadenitis patients; Ethiopia. Infect. Drug Resist. 14, 575\u2013584 (2021).","journal-title":"Infect. Drug Resist."},{"key":"1241_CR65","first-page":"5239529","volume":"2021","author":"G Diriba","year":"2021","unstructured":"Diriba, G. et al. Mycobacterial lineages associated with drug resistance in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia. Tuberc. Res. Treat. 2021, 5239529 (2021).","journal-title":"Tuberc. Res. Treat."},{"issue":"2","key":"1241_CR66","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5588\/ijtld.12.0195","volume":"17","author":"B Diriba","year":"2013","unstructured":"Diriba, B., Berkessa, T., Mamo, G., Tedla, Y. & Ameni, G. Spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates in Ethiopia. Int. J. Tuberc. Lung Dis. 17(2), 246\u2013250 (2013).","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"3","key":"1241_CR67","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1128\/JCM.05832-11","volume":"50","author":"VN Chihota","year":"2012","unstructured":"Chihota, V. N. et al. Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa. J. Clin. Microbiol. 50(3), 995\u20131002 (2012).","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"1241_CR68","doi-asserted-by":"publisher","first-page":"e01885","DOI":"10.1128\/JCM.01885-20","volume":"59","author":"J Shea","year":"2021","unstructured":"Shea, J. et al. Low-level rifampin resistance and rpoB mutations in Mycobacterium tuberculosis: an analysis of whole-genome sequencing and drug susceptibility test data in New York. J. Clin. Microbiol. 59(4), e01885-e1920 (2021).","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"1241_CR69","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/antibiotics3030317","volume":"3","author":"J Palomino","year":"2014","unstructured":"Palomino, J. & Martin, A. Drug resistance mechanisms in Mycobacterium tuberculosis. Antibiotics. 3(3), 317\u2013340 (2014).","journal-title":"Antibiotics."},{"issue":"6","key":"1241_CR70","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/mmi.13606","volume":"103","author":"V Molodtsov","year":"2017","unstructured":"Molodtsov, V., Scharf, N. T., Stefan, M. A., Garcia, G. A. & Murakami, K. S. Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis. Mol. Microbiol. 103(6), 1034\u20131045 (2017).","journal-title":"Mol. Microbiol."},{"issue":"2","key":"1241_CR71","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03168-22","volume":"14","author":"Y Patel","year":"2023","unstructured":"Patel, Y., Soni, V., Rhee, K. Y. & Helmann, J. D. Mutations in rpoB that confer rifampicin resistance can alter levels of peptidoglycan precursors and affect \u03b2-lactam susceptibility. MBio 14(2), e0316822 (2023).","journal-title":"MBio"},{"issue":"5","key":"1241_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198091","volume":"13","author":"E Kigozi","year":"2018","unstructured":"Kigozi, E. et al. Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda. PLoS ONE 13(5), e0198091 (2018).","journal-title":"PLoS ONE"},{"issue":"11","key":"1241_CR73","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1128\/JCM.43.11.5477-5482.2005","volume":"43","author":"M Zhang","year":"2005","unstructured":"Zhang, M. et al. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol. 43(11), 5477\u20135482 (2005).","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"1241_CR74","first-page":"540","volume":"14","author":"SR Moaddab","year":"2011","unstructured":"Moaddab, S. R., Farajnia, S., Kardan, D., Zamanlou, S. & Alikhani, M. Y. Isoniazid MIC and KatG gene mutations among Mycobacterium tuberculosis Isolates in Northwest of Iran. Iran. J. Basic Med. Sci. 14(6), 540\u2013545 (2011).","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"9","key":"1241_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135003","volume":"10","author":"AJ Niehaus","year":"2015","unstructured":"Niehaus, A. J., Mlisana, K., Gandhi, N. R., Mathema, B. & Brust, J. C. M. High prevalence of inhA promoter mutations among patients with drug-resistant tuberculosis in KwaZulu-Natal, South Africa. PLoS ONE 10(9), e0135003 (2015).","journal-title":"PLoS ONE"},{"key":"1241_CR76","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jgar.2021.06.009","volume":"26","author":"MA Reta","year":"2021","unstructured":"Reta, M. A., Alemnew, B., Abate, B. B. & Fourie, P. B. Prevalence of drug resistance-conferring mutations associated with isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Ethiopia: a systematic review and meta-analysis. J. Glob. Antimicrob. Resist. 26, 207\u2013218 (2021).","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"1","key":"1241_CR77","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12879-019-3764-2","volume":"19","author":"MT Khan","year":"2019","unstructured":"Khan, M. T. et al. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. BMC Infect. Dis. 19(1), 116 (2019).","journal-title":"BMC Infect. Dis."},{"issue":"6496","key":"1241_CR78","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1126\/science.aba9102","volume":"368","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol. Science 368(6496), 1211\u20131219 (2020).","journal-title":"Science"},{"key":"1241_CR79","first-page":"1","volume":"2015","author":"Y Xu","year":"2015","unstructured":"Xu, Y., Jia, H., Huang, H., Sun, Z. & Zhang, Z. Mutations found in embCAB, embR, and ubiA genes of ethambutol-sensitive and -resistant Mycobacterium tuberculosis clinical isolates from China. BioMed. Res. Int. 2015, 1\u20138 (2015).","journal-title":"BioMed. Res. Int."},{"issue":"11","key":"1241_CR80","doi-asserted-by":"publisher","first-page":"6837","DOI":"10.1128\/AAC.03285-14","volume":"58","author":"Z Cui","year":"2014","unstructured":"Cui, Z. et al. Mutations in the embC-embA intergenic region contribute to Mycobacterium tuberculosis resistance to ethambutol. Antimicrob Agents Chemother. 58(11), 6837\u20136843 (2014).","journal-title":"Antimicrob Agents Chemother."},{"issue":"4","key":"1241_CR81","doi-asserted-by":"publisher","first-page":"527","DOI":"10.5588\/ijtld.11.0202","volume":"16","author":"NTQ Nhu","year":"2012","unstructured":"Nhu, N. T. Q. et al. Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes. Int. J. Tuberc. Lung Dis. 16(4), 527\u2013531 (2012).","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"4","key":"1241_CR82","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1128\/microbiolspec.MGM2-0014-2013","volume":"2","author":"C Vilch\u00e8ze","year":"2014","unstructured":"Vilch\u00e8ze, C. & Jacobs, W. R. Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: Genes, mutations, and causalities. Microbiol. Spectr. 2(4), 2401 (2014).","journal-title":"Microbiol. Spectr."},{"issue":"4","key":"1241_CR83","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1473-3099(18)30004-5","volume":"18","author":"TM Walker","year":"2018","unstructured":"Walker, T. M. et al. A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. Lancet Infect. Dis. 18(4), 431\u2013440 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"1241_CR84","unstructured":"WHO. WHO consolidated guidelines on drug-resistant tuberculosis treatment (2022). https:\/\/iris.who.int\/bitstream\/handle\/10665\/311389\/9789241550529-eng.pdf."},{"issue":"11","key":"1241_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e31959","volume":"10","author":"C Teng","year":"2024","unstructured":"Teng, C. et al. Evaluation of genetic correlation with fluoroquinolones resistance in rifampicin-resistant Mycobacterium tuberculosis isolates. Heliyon. 10(11), e31959 (2024).","journal-title":"Heliyon."},{"issue":"3","key":"1241_CR86","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/BF01720538","volume":"19","author":"AR Aitkenhead","year":"1993","unstructured":"Aitkenhead, A. R. et al. International standards for safety in the intensive care unit Developed by the international task force on safety in the intensive care unit. Intensive Care Med. 19(3), 178\u2013181 (1993).","journal-title":"Intensive Care Med."},{"key":"1241_CR87","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jgar.2023.05.001","volume":"34","author":"Q An","year":"2023","unstructured":"An, Q., Lin, R., Yang, Q., Wang, C. & Wang, D. Evaluation of genetic mutations associated with phenotypic resistance to fluoroquinolones, bedaquiline, and linezolid in clinical Mycobacterium tuberculosis: A systematic review and meta-analysis. J. Glob. Antimicrob. Resist. 34, 214\u2013226 (2023).","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"7","key":"1241_CR88","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1089\/mdr.2019.0339","volume":"27","author":"Y Hu","year":"2021","unstructured":"Hu, Y. et al. Genotyping and molecular characterization of fluoroquinolone\u2019s resistance among multidrug-resistant Mycobacterium tuberculosis in Southwest of China. Microb. Drug Resist. Larchmt N. 27(7), 865\u2013870 (2021).","journal-title":"Microb. Drug Resist. Larchmt N."},{"issue":"1","key":"1241_CR89","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/excr.1996.3408","volume":"230","author":"M Shago","year":"1997","unstructured":"Shago, M. et al. Modulation of the retinoic acid and retinoid X receptor signaling pathways in P19 embryonal carcinoma cells by calreticulin. Exp. Cell Res. 230(1), 50\u201360 (1997).","journal-title":"Exp. Cell Res."},{"issue":"2","key":"1241_CR90","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/mdr.2011.0063","volume":"18","author":"FA Sirgel","year":"2012","unstructured":"Sirgel, F. A. et al. Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis. Microb. Drug Resist. Larchmt N. 18(2), 193\u2013197 (2012).","journal-title":"Microb. Drug Resist. Larchmt N."},{"issue":"2","key":"1241_CR91","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1128\/JCM.01476-09","volume":"48","author":"LE Via","year":"2010","unstructured":"Via, L. E. et al. Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis. J. Clin. Microbiol. 48(2), 402\u2013411 (2010).","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"1241_CR92","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12900-016-0056-6","volume":"16","author":"JM Wagner","year":"2016","unstructured":"Wagner, J. M. et al. Structures of EccB1 and EccD1 from the core complex of the mycobacterial ESX-1 type VII secretion system. BMC Struct. Biol. 16(1), 5 (2016).","journal-title":"BMC Struct. Biol."},{"issue":"4","key":"1241_CR93","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1556\/1886.2020.00028","volume":"10","author":"S Roy","year":"2020","unstructured":"Roy, S., Ghatak, D., Das, P. & BoseDasgupta, S. ESX secretion system: The gatekeepers of mycobacterial survivability and pathogenesis. Eur. J. Microbiol. Immunol. 10(4), 202\u2013209 (2020).","journal-title":"Eur. J. Microbiol. Immunol."},{"issue":"1","key":"1241_CR94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/22221751.2020.1861913","volume":"10","author":"Q Guo","year":"2021","unstructured":"Guo, Q., Bi, J., Wang, H. & Zhang, X. Mycobacterium tuberculosis ESX-1-secreted substrate protein EspC promotes mycobacterial survival through endoplasmic reticulum stress-mediated apoptosis. Emerg. Microbes Infect. 10(1), 19\u201336 (2021).","journal-title":"Emerg. Microbes Infect."},{"issue":"10","key":"1241_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078351","volume":"8","author":"A Serafini","year":"2013","unstructured":"Serafini, A., Pisu, D., Pal\u00f9, G., Rodriguez, G. M. & Manganelli, R. The ESX-3 secretion system is necessary for iron and zinc homeostasis in Mycobacterium tuberculosis. PLoS ONE 8(10), e78351 (2013).","journal-title":"PLoS ONE"},{"issue":"4","key":"1241_CR96","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fvets.2017.00107","volume":"30","author":"Z Xu","year":"2017","unstructured":"Xu, Z. et al. Generation of monoclonal antibodies against Ag85A antigen of Mycobacterium tuberculosis and application in a competitive ELISA for serodiagnosis of bovine tuberculosis. Front. Vet. Sci. 30(4), 107 (2017).","journal-title":"Front. Vet. Sci."},{"issue":"18","key":"1241_CR97","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1128\/JB.00359-16","volume":"198","author":"M Sritharan","year":"2016","unstructured":"Sritharan, M. Iron homeostasis in Mycobacterium tuberculosis: Mechanistic insights into siderophore-mediated iron uptake. J. Bacteriol. 198(18), 2399\u20132409 (2016).","journal-title":"J. Bacteriol."},{"issue":"12","key":"1241_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.876667","volume":"11","author":"GM Rodriguez","year":"2022","unstructured":"Rodriguez, G. M., Sharma, N., Biswas, A. & Sharma, N. The iron response of Mycobacterium tuberculosis and its implications for tuberculosis pathogenesis and novel therapeutics. Front. Cell Infect. Microbiol. 11(12), 876667 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"1","key":"1241_CR99","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0041-3879(90)90060-L","volume":"71","author":"ZF Zainuddin","year":"1990","unstructured":"Zainuddin, Z. F. & Dale, J. W. Does Mycobacterium tuberculosis have plasmids?. Tubercle 71(1), 43\u201349 (1990).","journal-title":"Tubercle"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01241-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:02:45Z","timestamp":1746709365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01241-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1241"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01241-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable as there is not any animal or human subject involved directly in the study. The study utilized publicly available raw WGS data. Demographic and clinical data of patients were accessed from an open-source database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"16076"}}